Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Sep 1, 2026
Reporting period
Not applicable
Filed with the SEC
Sep 3, 2026
OfficerOption exercise
Context
Classification
option exercise
Code M — exercise or conversion of a derivative security
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0002022345-26-000002
Filed / recorded
Sep 3, 2026, 9:41 PM UTC
Added to OQRO
Oct 6, 2026, 4:40 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
BIO-RAD LABORATORIES, INC.
Issuer CIK
12208
Ticker
BIO BIO.B
Reporting person
James Barry
Relationship
Officer
Officer title
EVP, President, LSG
Security
Restricted Stock Units
Table
Derivative (Table II)
Transaction date
Sep 1, 2026
Transaction code
M
Shares / units
174
Price per share
$0.00
Acquired / disposed
Disposed (D)
Shares owned after
0
Ownership form
Direct
Amendment
No
Footnotes from the filing
Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
On September 1, 2022, the reporting person was granted 694 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.